Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Patent and ...
STAT23h
Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability
Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.
STAT1d
FDA’s Troy Tazbaz returns to Oracle after a short stint shaping health AI rules
Troy Tazbaz, the outgoing director of the FDA's digital health center, is returning to Oracle as a senior vice president.